| Literature DB >> 27235609 |
Jennifer J Wright1, Tracy S Tylee2.
Abstract
Type 2 diabetes (T2DM) is a common condition. Treatment of diabetes and related complications can be complex. In addition to lifestyle changes, medications play an important role in controlling patients' blood glucose levels and preventing complications. From an individual and societal standpoint, it is also an expensive disease. Medical spending attributed to diabetes per individual is significant. With appropriate therapy, patients can lead full, healthy lives with the disease, so making informed decisions regarding pharmacotherapy for T2DM is clearly of great importance.Entities:
Keywords: DPP-4 inhibitor; GLP-1 analog; Insulin; Metformin; SGLT-2 inhibitor; Sulfonylurea; Type 2 diabetes
Mesh:
Substances:
Year: 2016 PMID: 27235609 DOI: 10.1016/j.mcna.2016.03.014
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456